TITLE

ELSID-Diabetes study-evaluation of a large scale implementation of disease management programmes for patients with type 2 diabetes. Rationale, design and conduct -- a study protocol [ISRCTN08471887]

AUTHOR(S)
Joos, Stefanie; Rosemann, Thomas; Heiderhoff, Marc; Wensing, Michel; Ludt, Sabine; Gensichen, Jochen; Kaufmann-Kolle, Petra; Szecsenyi, Joachim
PUB. DATE
January 2005
SOURCE
BMC Public Health;2005, Vol. 5 Issue 1, p99
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Diabetes model projects in different regions of Germany including interventions such as quality circles, patient education and documentation of medical findings have shown improvements of HbA1c levels, blood pressure and occurrence of hypoglycaemia in before-after studies (without control group). In 2002 the German Ministry of Health defined legal regulations for the introduction of nationwide disease management programs (DMP) to improve the quality of care in chronically ill patients. In April 2003 the first DMP for patients with type 2 diabetes was accredited. The evaluation of the DMP is essential and has been made obligatory in Germany by the Fifth Book of Social Code. The aim of the study is to assess the effectiveness of DMP by example of type 2 diabetes in the primary care setting of two German federal states (Rheinland-Pfalz and Sachsen-Anhalt). Methods/Design: The study is three-armed: a prospective cluster-randomized comparison of two interventions (DMP 1 and DMP 2) against routine care without DMP as control group. In the DMP group 1 the patients are treated according to the current situation within the German-Diabetes-DMP. The DMP group 2 represents diabetic care within ideally implemented DMP providing additional interventions (e.g. quality circles, outreach visits). According to a sample size calculation a sample size of 200 GPs (each GP including 20 patients) will be required for the comparison of DMP 1 and DMP 2 considering possible drop-outs. For the comparison with routine care 4000 patients identified by diabetic tracer medication and age (> 50 years) will be analyzed. Discussion: This study will evaluate the effectiveness of the German Diabetes-DMP compared to a Diabetes-DMP providing additional interventions and routine care in the primary care setting of two different German federal states.
ACCESSION #
29361859

 

Related Articles

  • Using the Glitazones to Manage Diabetes. Sadovsky, Richard // American Family Physician;01/15/2001, Vol. 63 Issue 2, p369 

    Presents an abstract of the study `The Glitazones: Proceed With Caution,' by D. Krische, from the July 2000 issue of the `Western Journal of Medicine,' focusing on the management of diabetes.

  • Diabetology.  // Caribbean Health;Apr1999, Vol. 2 Issue 1, p30 

    The article provides information on the United Kingdom Prospective Diabetes Study (UKPDS) in Great Britain. According to the article, UKPDS was established in 1977, in order to show the risks and the benefits of Type 2 diabetes treatment. In addition, it includes several intensive treatments for...

  • WALL STREET CHOICE ACOMPLIA ADDS WEIGHT TO SANOFI-AVENTIS FORECAST. Baum, Andrew // Medical Marketing & Media;Jul2005, Vol. 40 Issue 7, p30 

    Reports on the price of Sanofi-Aventis' Plavix drug for diabetes. Competition facing the company.

  • Diabetes. Gadsby, Roger // Update;Feb2007, Vol. 74 Issue 2, p19 

    The article focuses on various developments related to the treatment of diabetes in Great Britain. The Heart Protection Study (HPS) found that the incidence of major vascular events in diabetics was reduced by 20 percent by treating them with a 40 mg dose of simvastatin compared with placebo....

  • Photopheresis at onset of type 1 diabetes: a randomised, double blind, placebo controlled trial. Ludvigsson, J.; Samuelsson, U.; Ernerudh, J.; Johansson, C.; Stenhammar, L.; Berlin, G. // Archives of Disease in Childhood;Aug2001, Vol. 85 Issue 2, p149 

    Background-In recent years photopheresis, an extracorporeal form of photochemotherapy using psoralen and ultraviolet A irradiation of leucocytes, has been claimed to be an effective form of immunomodulation. Aim-To evaluate its effect in type 1 diabetes we performed a double blind, controlled...

  • Studie čtyÅ™ systémů měření glykovaného hemoglobinu HbA1c v režimu POCT. FRIEDECKÝ, B.; KRATOCHVÍLA, J.; ŠPIRKOVÁ, J.; BUDÍNA, M.; PALIČKA, V. // General Practitioner / Prakticky Lekar;Aug2011, Vol. 91 Issue 8, p485 

    Four POCT systems designed for HbA1c measurement in blood were compared with a high quality laboratory method based on the HPLC principle and successfully controlled by a proficiency testing program provided by the European reference laboratory for HbA1c (in The Netherlands). The accuracy of all...

  • Role of Hepatic Glycogen Breakdown in Defective Counterregulation of Hypoglycemia in Intensively Treated Type 1 Diabetes. Kishore, Preeti; Gabriely, Ilan; Cui, Min-Hui; Di Vito, Joseph; Gajavelli, Srikanth; Hwang, Jong-Hee; Shamoon, Harry // Diabetes;Mar2006, Vol. 55 Issue 3, p659 

    Impairment of hypoglycemic counterregulation in intensively treated type 1 diabetes has been attributed to deficits in counterregulatory hormone secretion. However, because the liver plays a critical part in recovery of plasma glucose, abnormalities in hepatic glycogen metabolism per se could...

  • Nonsurgical Management of Primary Hyperparathyroidism. Farford, Bryan; Presutti, R. John; Moraghan, Thomas J. // Mayo Clinic Proceedings;Mar2007, Vol. 82 Issue 3, p351 

    Primary hyperparathyroidism is the most common cause of hypercalcemia In the outpatient setting and is typically caused by a single benign parathyroid adenoma. Most patients with hyper-parathyroidism are postmenopausal women. Patients can be asymptomatic or minimally symptomatic....

  • Dealing with diabetes. Shulman, Joey // Alive: Canada's Natural Health & Wellness Magazine;Nov2005, Issue 277, p40 

    The article focuses on the symptoms, causes and management of type 2 diabetes. The rates of those diagnosed with diabetes for the past 30 years have increased at an alarming pace. The World Health Organization says the situation is considered a healthcare epidemic and the situation is serious...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics